The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH
- 20 December 2001
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 30 (1) , 27-28
- https://doi.org/10.1038/ng809
Abstract
Erythropoietic protoporphyria (EPP) is an inherited disorder of heme biosynthesis caused by a partial deficiency of ferrochelatase (FECH, EC 4.99.1.1)1,2. EPP is transmitted as an autosomal dominant disorder3 with an incomplete penetrance1. Using haplotype segregation analysis, we have identified an intronic single nucleotide polymorphism (SNP), IVS3–48T/C, that modulates the use of a constitutive aberrant acceptor splice site. The aberrantly spliced mRNA is degraded by a nonsense-mediated decay mechanism (NMD), producing a decreased steady-state level of mRNA and the additional FECH enzyme deficiency necessary for EPP phenotypic expression.Keywords
This publication has 9 references indexed in Scilit:
- RET genotypes comprising specific haplotypes of polymorphic variants predispose to isolated Hirschsprung diseaseJournal of Medical Genetics, 2000
- Specific polymorphisms in the RETproto-oncogene are over-represented in patients with Hirschsprung disease and may represent loci modifying phenotypic expressionJournal of Medical Genetics, 1999
- Inheritance in Erythropoietic Protoporphyria: A Common Wild-Type Ferrochelatase Allelic Variant With Low Expression Accounts for Clinical ManifestationBlood, 1999
- Erythropoietic protoporphyriaBritish Journal of Dermatology, 1994
- Recessive inheritance of erythropoietic protoporphyria with liver failureThe Lancet, 1994
- Human Erythropoietic Protoporphyria: Two point mutations in the ferrochelatase geneBiochemical and Biophysical Research Communications, 1991
- An HPLC assay for rat liver ferrochelatase activityBiomedical Chromatography, 1987
- Genetic aspects of erythropoietic protoporphyriaAnnals of Human Genetics, 1984